18 December 2024 : Clinical Research
Association Between Body Mass Index and Survival in Patients with De Novo Metastatic Non-Small Cell Lung Cancer
Muslih Ürün
ABEF 1, Gürkan Güner AEF 2*, Yasin Sezgin BEF 1, Abdullah Sakin AEF 3, Saadettin Kılıçkap CDE 4
DOI: 10.12659/MSM.946751
Med Sci Monit 2024; 30:e946751
Table 1 Clinical and demographic data.
| Characteristics | Total (n=289) |
|---|---|
| Age (mean±SD) | 60.1±11.1 |
| Age (n, %) | |
| <60 | 145 (50.2) |
| ≥60 | 144 (49.8) |
| Sex (n, %) | |
| Female | 48 (16.6) |
| Male | 241 (83.4) |
| Height, cm (mean±SD) | 167.5±8.1 |
| Weight, kg (mean±SD) | 68.7±13 |
| BMI, kg∕m (mean±SD) | 24.5±4.5 |
| BMI, kg∕m (n, %) | |
| <25 | 175 (60.6) |
| ≥25 | 114 (39.4) |
| Smoking (n, %) | |
| Yes | 246 (85.1) |
| No | 43 (14.9) |
| ECOG PS (n, %) | |
| 0 | 92 (31.8) |
| 1 | 70 (24.2) |
| 2 | 80 (27.7) |
| 3 | 47 (16.3) |
| Patologic diagnosis (n, %) | |
| Squamous cell carcinoma | 79 (27.3) |
| Adenocarcinoma | 146 (50.5) |
| NOS | 64 (22.1) |
| The site of metastasis (n, %) | |
| Brain | 76 (26.3) |
| Liver | 49 (17) |
| Bone | 128 (44.3) |
| Surrenal | 62 (21.5) |
| Pleura | 42 (14.5) |
| Counter-Lung | 62 (21.5) |
| Other | 31 (10.7) |
| Final situation | |
| Alive | 63 (21.8) |
| Dead | 226 (78.2) |
| Results were presented as mean±standard deviation or n (%). SD – standard deviation; BMI – body mass index; ECOG PS – Eastern Cooperative Oncology Group performance status; NOS – not otherwise specified. | |